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Cardiomyocytes in pulmonary veins (PVs) have been reported in rodents and humans. In humans they were 
related to atrial arrhythmias, including atrial fibrillation (AF). To investigate histological similarities and 
differences in PV cardiomyocyte localization and distribution, we performed comparative light and electron 
microscopic studies on humans, rats and mice, and generated a transgenic mouse strain. Results on mice 
(C57BL/6 and BALBc) and rats (Wistar) revealed that cardiomyocytes regularly extend from the hilus along 
venous vessels into the lung tissue surrounding individual intrapulmonary veins of varying diameters 
(70-250µm). The cardiomyocytes showed the ultrastructure of a normal working myocardium with intact 
intercalated discs and tightly packed contractile filaments. In both lung and hilus cardiomyocytes were localized 
either close to the basal lamina of the endothelium or separated from it by smooth muscle cells and/or collagen 
fibres. In humans (autopsies, n=20) extrapericardiac cardiomyocytes were only found in 23 out of 78 veins and 
showed an incomplete sleeve at the lung hilus. In addition, cardiomyocytes occurred significantly more often in 
right than in left veins, however, never in intrapulmonary veins.  
We discuss the hypothesis that the variance in distribution of PV cardiomyocytes in humans and rodents might 
reflect the difference in pathogenesis and development of AF. 
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Introduction 
Animal and human histological studies on 
pulmonary veins (PVs), which date back to the 19th 
century, reported the presence of cardiac cells beyond 
the atrio-venous junctions [1-5]. The observations of 
independent pulsations of PVs have raised the 
possibility that PVs contain pacemaker cells [6]. 
Morphological studies on rats suggested the presence 
of conducting cells in PVs [7,8] and Perez-Lugones et 
al. found pace-maker cells, transitional cells and 
Purkinje cells in human PVs [9]. Spontaneous electrical 
activity with phase 4 depolarization was for the first 
time demonstrated in guinea pigs [10]. Moreover, it 
was shown that digitalis could trigger atrial 
tachyarrhythmias in PV tissue preparations [11]. 
Studies on patients with drug-refractory paroxysmal 
atrial fibrillation identified potential triggers of AF 
from electrically active cardiomyocytes localized in the 
ostia of pulmonary veins [12]. Atrial fibrillation is the 
most common cardiac arrhythmia in humans, 
however, not of major concern in small rodents. 
Nevertheless, ontological and functional investigations 
on pulmonary myocardium have been extensively 
performed in mice and rats (e.g. [13,14]). This fact 
prompted us to perform a comparative histological 
and ultrastructural study on the occurrence of 
cardiomyocytes along PVs in humans, mice and rats. 
We focussed on the distribution of cardiomyocytes in 
PVs as well as their topographical relation to the vessel 
wall. 
Materials und Methods  
Animal care 
Animal care and all experimental procedures 
were performed in strict accordance to the German 
and National Institutes of Health animal legislation 
guidelines and were approved by the local animal care 




Lungs of 19 mice (C57BL/6 and BALBc) and 3 
rats (Wistar) were excised and fixed in 4% buffered 
formalin, dehydrated in graded ethanol and 
embedded in paraffin by standard methods. Four μm 
thick longitudinal sections of the hilus were mounted 
on positively charged glass slides. Subsequently, the 
sections were stained with hematoxilin/eosin, elastic 
van Gieson and Masson`s trichrome according to 
standard procedures. For measurements of the vessel 
size a Periplan ocular GF12,5x/20 with integrated scale 
(Leitz) was used. 
Additionally, lung veins from 20 randomly 
chosen human autopsy cases (14 males, 6 females; 
median age 68 years (range 46 – 83 years) were 
investigated. In every case circular cross-sections were 
taken at the lung hilus, and at the outer and inner 
surface of the pericardium. The tissue samples were 
processed and stained as described above. In total 78 
human lung veins were studied (Table 1). 
Table 1. Cardiomyocytes in human lung veins (autopsy cases n 
= 20). 





upper vein  19 / 20  9 / 19  0,001*
lower vein  16 / 19  7 / 19  0,007*
right veins 
both veins  35 / 39  16 / 38  <0,001*
upper vein  16 / 20  4 / 20  <0,001*
lower vein  15 / 19  3 / 19  <0,001*
A 
left veins 
both veins  31 / 39  7 / 39  <0,001*
 
  right veins  left veins  p-value
upper vein  19 / 20  16 / 20 
lower vein  16 / 19  15 / 19 
inside the 
pericardium 
both veins  35 / 39  31 / 39 
0,347 
upper vein  9 / 19  4 / 20 
lower vein  7 / 19  3 / 19 
outside the 
pericardium 
both veins  16 / 38  7 / 39 
0,026*
upper vein  4 / 20  1 / 20 
lower vein  4 / 19  1 / 19 
B 
hilus 
both veins  8 / 39  2 / 39 
0,087 
A, Comparison inside/outside the pericardium of left and right 
veins with cardiomyocytes. 
B, Comparison left/right veins with cardiomyocytes inside and 
outside the pericardium.  
Statistical significance (*) was accepted at p ≤ 0.05. 
Ultrastructural studies  
For ultrastructural studies lung tissue including 
the hilus region of mice and rats were fixed in 6.25% 
phosphate buffered glutaraldehyde, postfixed in 
osmium tetroxide (1% in distilled water, 2 hours), 
dehydrated in ethanol and embedded in Epon. 
Semithin sections were stained with 
azure-methylene-blue. Ultrathin sections were 
counterstained with uranyl acetate and lead citrate and 
examined with a Philips EM 420 transmission electron 
microscope. 
Transgenic mice (αMHCp-LacZ-hgh) 
The presence and localization of cardiomyocytes 
in murine pulmonary veins was investigated by means 
of  β-galactosidase analyses in transgenic mice 
(αMHCp-lacZ-hgh) with cardiomyocyte-specific 
expression of the LacZ reporter gene.  
Cloning strategy of αMHCp-LacZ-hgh. The vector 
αMHCp-MCS-hgh was a kind gift from Dr. J. Robbins 
(Cincinnati, USA). This Vector (pBS II sk+) contained 
the 5537 bp promoter fragment upstream of the αMHC 
gene from mouse and the first 3 noncoding 
exons/introns of the αMHC gene. The multiple 
cloning side was followed by the sequence of the 
human growth hormone poly(A) signal (hgh). The 
LacZ coding sequence was PCR-amplified from 
pcDNA4/TO/lacZ (Invitrogen) using two pairs of 
sequence specific primers. After cloning the fragments 
into Blunt II TOPO (Invitrogen) they were again 
isolated using Sal I/BssH II and BssH II/HindIII. After 
ligation using the BssH II restriction site the complete 
LacZ cDNA was integrated into αMHCp-MCS-hgh 
using the restriction enzymes Sal I and Hind III. 
Establishing  αMHCp-LacZ-hgh transgenic mouse 
lines. The transgene (αMHCp-LacZ-hgh) was isolated 
from the vector using a Not I restriction enzyme, and 
gel-purified using QIAquick Gel Extraction Kit 
(Qiagen).  αMHCp-LacZ-hgh transgenic mice were 
established by microinjection of 1-3 µg transgene into 
the pronuclei of fertilized FVB/N oocytes [15]. After 
crossing with vasectomised males the oocytes were 
retransferred into the oviduct of pseudo pregnant 
females. The transgenic mouse lines were established 
and propagated in FVB-inbred-strains. 
β-galactosidase (X-Gal) staining. Animals were 
killed by an anesthetic overdose. The hearts were 
exposed, cannulated through the left ventricle, and 
tissue was perfused with 15 ml of phosphate buffer 
(pH=7.4) (PBS). Then the lungs were fixed with 50 ml 
of 3% paraformaldehyde in PBS, and finally washed 
with PBS for 3 min. After dissection, the lungs were 
rinsed 3 times with PBS for 5 minutes each. 
For whole mount staining, the lungs were 
incubated in 0,1% X-gal, 5mM potassium ferricyanide, 
5mM potassium ferrocyanide, 1mM magnesium 
chloride, 0,002% NP-40, 0,01% sodium deoxycholate, 
PBS, pH=7,0, at 37°C for 3 hours to overnight. The 
lungs were rinsed in PBS, and postfixed at 4°C 
overnight in 2% paraformaldehyde, 0,1% 
glutaraldehyde, PBS. Postfixed lungs were rinsed in Int. J. Med. Sci. 2008, 5 
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PBS, dissected again in some cases, and photographed 
under a binocular microscope (Carl Zeiss OPMI-FR). 
For histological analyses, the dissected lungs 
were equilibated in a graded series of sucrose, and 
mounted in OCT (Tissue-Tek) using liquid 
nitrogen-cooled isopentane. Ten to 20 μm thick 
cryosections were mounted on slides, postfixed in 2% 
paraformaldehyde in PBS, rinsed in PBS, and stained 
using the same solutions as described above. The 
sections were then rinsed in PBS, postfixed in 2% 
paraformaldehyde, 0,1% glutaraldehyde, PBS, rinsed 
again and photographed under a optical microscope 
(Leica DM RB). 
Statistics 
For statistical analyses of the autopsy results the 
Fisher’ exact test was applied. Statistical significance 
was accepted at p ≤ 0.05. 
Results 
Lung veins in mice and rats 
Both in mice and rats a coat of cardiomyocytes 
was found within pulmonary veins of lungs (Fig. 1A, 
B) and at the lung hilus (Fig. 1C, D). Within the lungs 
the cardiomyocytic coat was present in veins 
measuring 70-250 µm, but not in every vessel of the 
same size (Fig. 1A). The cardiomyocyte coat varied 
between 4-8 cell layers at the hilus and 1 to 2 layers at 
intrapulmonal locations. However, cardiomyocyte 
coverage was highly variable not only among 
specimens, but among veins of the same specimen. 
Furthermore, in some areas the cardiomyocytic coat 
was partially incomplete or discontinuous, in 
particular within lungs (Fig. 1A, B). This fact was 
conspicuously evidenced in pulmonary veins of 
transgenic mice by αMHC-specific lacZ staining (Fig. 
2). Ultrastructural studies disclosed that both within 
the lungs and at the lung hilus cardiomyocytes were 
located either adjacent to the basal lamina (Fig. 3A, D) 
or separated by smooth muscle cells, collagen and 
elastic fibres (Fig. 3B, C). The cardiomyocytes showed 
the normal fine structure of a working myocardium, 
i.e. rich in contractile filaments, mitochondria, and 
lamellar cristae. The cells formed regular cell to cell 
contacts at intercalated discs (Fig. 3A, B) and were 
separated from the surrounding lung by collagen 
fibres and fibrocytes (Fig. 3 E).   
Lung veins in humans 
In humans, cardiomyocytes covered the lung 
veins up to the inner surface of the pericardium in 84% 
(66/78) of the veins examined, but were present near 
the outer surface of the pericardium only in 29% 
(23/78) of them (Table 1A). Sixteen of the 23 veins with 
cardiomyocytes near the outer surface of the 
pericardium were right lung veins and only 7 were left 
lung veins (p=0.026) (Table 1B). At the hilus, 
cardiomyocytes were found only in 13% (10/78) of 
lung veins belonging to 5 different autopsy cases 
(p<0.0001). In cross sections the sleeve of 
cardiomyocytes covered between 10% and 100% of the 
total circumference of a vein. The maximum coverage 
was found near the auricular ostia. Histologically, the 
cardiomyocytes showed the typical compact 
cytoplasm of regular cardiomyocytes of the working 




Fig. 1: Light microscopy of intrapulmonary veins of mice 
(A, B), and extrapulmonary veins of mice (C) and rats (D) at 
the lung hilus. A, The left intrapulmonary vein shows a 
continuous outer cell layer of cardiomyocytes (double arrow). 
The right vein of the same size has only a few discontinous 
cardiomyocytes (arrow). B, Intrapulmonary vein with a 
segmental coat of cardiomyocytes. Layers of cardiomyocytes 
are seen in the outer part of extrapulmonary veins of mice (C, 
arrow) and rats (D, asterisk). In D (arrow), but not in C, an inner 
rim of smooth muscle cells is present. Obj. magnification: A, 
10x; B, 16x; C, 25x; D, 40x. 




Fig. 2: Whole mount (A,B) and tissue section (C,D) β-gal staining of PVs of αMHCp-LacZ-hgh transgenic mice. Blue β-gal 
staining is evident only in cardiomyocytes covering the PVs. Note that the cardiomyocytic coverage is more prominent in the 
proximal (long arrows in B) than in the distal (short arrows in B) portions of the extrapulmonary veins. At intrapulmonary locations 
(C, D), the cardiomyocytic coverage is even more reduced. Note the striated appearance of β-gal-positive cells (inset in D). Original 
magnification: C, 200x; D, 400x; inset in D, 630x 
 
Fig. 3: Ultrastructure of intrapulmonary veins of 
mouse (A, C) and rat (B) and extrapulmonary 
vein of rat (D) at the lung hilus and relation of 
intrapulmonary lung vein (mouse) to lung 
parenchyma (E). A, Intrapulmonary vein (mouse). 
Directly underneath the basal/ elastic lamina (**) 
cardiomyocytes of the working myocardium type are 
seen.  B, Intrapulmonary vein of rat showing a 
smooth muscle cell (sm) interposed between 
endothelium and the cardiomyocytic layer. C, 
Intrapulmonary vein of mouse, with a smooth muscle 
cell layer (sm) and elastic fibres (***) separating the 
cardiomyocytes from the endothelium. D, 
Extrapulmonary vein (rat) at the lung hilus. The 
cardiomyocyte layer is directly underneath the basal 
lamina.  E, Relation of intrapulmonary lung vein 
(mouse) to lung parenchyma. The vein is devoid of a 
smooth muscle cell coat. The cell layer of 
cardiomyocytes (C) is separated from the lung 
parenchyma (LP) by collagen fibres (double arrow) 
and fibrocyte (+). L = lumen, N = nucleus of 
cardiomyocyte, E = erythrocyte; C = cardiomyocyte, 
LP = lung parenchyma, sm = smooth muscle cells, cf 
= contractile filaments, m = mitochondra, + = 
fibrocyte, * = endothelium, ** = basal/elastic lamina, 
*** = elastic material; arrow = intercalated disc, 
double arrow = collagen fibers, arrow head = 
endothelium with adjacent basal/elastic lamina. 
Original magnification: A, D: 10.000x; B, C: 





Fig. 4: Light microscopy of human lung veins. Masson´s 
trichrome staining of human lung veins at the lung hilus with an 
incomplete sleeve of cardiomyocytes (arrow). L = lumen, cf = 
contractile filament. Original magnification: A, 25x; B, 400x 
 
Discussion 
Our histological and ultrastructural study on the 
occurrence of cardiomyocytes in PVs of humans as 
well as of mice and rats showed major differences in 
cardiomyocyte distribution and localization. These 
data might be of considerable relevance in terms of 
understanding the development of AF in humans as 
well as on the choice of animal models of AF as 
discussed below. 
In our study on mice and rats we found 
cardiomyocytes forming part of PV walls in all lungs 
under investigation. In mice, their occurrence and 
distribution was not related to a specific strain, being 
similar both in C57BL/6 mice and in BALBc-mice. 
Cardiomyocytes were found in vessels with diameters 
varying from 70 - 250µm. However, their occurrence 
had a random character, not being present in every 
vessel of the same size. At the hilus the presence of 
cardiomyocytes was a constant feature, whereas in 
vessels less than 70µm no cardiomyocytes were found. 
These data were in accordance with the lacZ 
expression in transgenic αMHCp-lacZ mice that were 
generated to get a more overall impression of 
cardiomyocyte distribution in mice. 
In mice and rats, the structural relationship of 
cardiomyocytes within the vessel wall was also 
variable. Cardiomyocytes could be found either in 
close contact with the basal lamina of the endothelium 
without intervening smooth muscle cells or in a more 
outward position adjacent to smooth muscle cells, 
collagen and elastic fibres. Detailed ultrastructural 
data on the topographical variability of PV 
cardiomyocytes are only rarely available in the 
literature [7,8,16-18]. The observed structural 
variability observed in our study, however, may 
explain the discrepancy of the results of some studies 
on the existence of a layer of smooth muscle cells 
between the endothelial lining and the external 
cardiomyocyte sleeve. The intimate location near the 
endothelium at least of the intrapulmonal 
cardiomyocytes often without interposed smooth 
muscle cells further indicates that they represent an 
integral part of the venous wall as previously 
suggested [8]. 
In humans, cardiomyocytes did not occur in 
intrapulmonary veins. Furthermore, 87% of the lung 
veins at the lung hili were free of them. In the 
literature, the percentage of individuals with 
cardiomyocytes at any level of the extrapulmonary 
veins ranged from 68% to 97% [19-21]. In our series, 
84% of autopsy cases showed cardiomyocyte coverage 
of pulmonary veins, a percentage similar to that 
reported by other authors [5]. However, this coverage 
was not continuous in all locations. Maximal coverage 
was found near the auricular ostium, whereas 
incomplete layers appeared near the pericardium. 
Moreover, only in 30% of the autopsy cases examined, 
cardiomyocytes surpassed the pericardial limit 
indicating that the pericardium represents a natural 
boarder. Previous studies indicated that in humans the 
cardiomyocytic perivenous extension varied between 
25-48 mm at maximum [1,19,20,22] and 1.8-3 mm at 
minimum [1,20], but no direct reference to the 
pericardial limit was made. In our study, we found 
that  extrapericardiac cardiomyocytes occurred 
significantly more often in right veins than in left 
veins. Large interindividual variabitility, however, is a 
well known feature [19,20]. In PVs of patients with 
atrial fibrillation P cells, transitional cells, and Purkinje Int. J. Med. Sci. 2008, 5 
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cells have been documented [9]. Node-like cells have 
been found in PVs of rat hearts [7]. However, our 
present results indicate that PV cardiomyocytes belong 
exclusively to the working myocardium both in 
humans and rodents. Furthermore, according to the 
expression of the conducting gap-junction protein 
Cx40 and the missing expression of Hcn4 in mice, a 
pacemaker channel essential for pacemaker acivity in 
humans [23,24], the existence of a nodal-like 
phenotype is unlikely in PV cardiomyoytes of mice 
[14].  
In our study, we found that the distribution of 
cardiomyocytes in mice and rats is similar, confirming 
previous results [7,16,18]. In both rodent species, 
pulmonary vein cardiomyocytes extend from the 
atrium through the hilus into the lungs. However, this 
distribution differs strongly from that of humans, in 
which pulmonary vein cardiomyocytes never reach 
the lungs indicating that in humans the pericardium 
presents a natural barrier for PV cardiomyocytes. It is 
of special interest to know that the anatomical location 
of intrapulmonary lung veins also differs in mice and 
rats from that in humans. In both rodents the 
pulmonary veins follow the pulmonary arteries and 
bronchus, whereas in humans the lung veins follow an 
independent course in fibrous interlobular septae. It is 
tempting to speculate that the observed differences in 
the pulmonary vein architecture may account for a 
different physiological function. According to a 
detected propagation of the action potential towards 
the lung murine PV cardiomyocytes might have a 
“throttle valve”-like action role [8]. By preventing 
backflow of blood into the lung during diastole they 
might protect the organ from edema formation. Due to 
lower heart beat rate a similar action is not necessary in 
humans. 
Beside these anatomical differences, the basic 
histological and ultrastructural characteristics of PV 
cardiomyocytes are very similar in rodents and man. 
In both, working myocytes surround PVs in intimate 
association with the endothelium or separated from it 
by a layer of SMCs. Accordingly, and in contrast to old 
views of cardiac inflow tract development, it has been 
shown that the early events in the development of the 
pulmonary vein are likely to be the same in all 
mammals, including humans [25]. Experimental 
research on mouse embryogenesis indicates that 
cardiomyocitic coverage of the pulmonary veins 
develop as an outgrowth of atrial cells that migrate to 
the lung primordium to finally connect to the 
pulmonary vein vascular plexus[13,26,27]. However, 
others favoured the hypothesis that lung mesenchymal 
cells differentiate into myocardial cells in situ [28]. 
Recently, Mommersteeg et al. confirmed the later 
hypothesis and described a biphasic model for mice 
[14]. They proposed that first a mesenchymal-derived 
myocardial population forms de novo at the 
connection of the pulmonary vein and the atrium. In a 
second wave, this pulmonary myocardium population 
expands by proliferation, expansion and migration to 
form the pulmonary vein myocardial sleeve. In their 
study Mommersteeg et al. found that atrial and 
mesenchymal-derived cardiomyocytes chronologically 
differ in the expression of cardiac tropnin I (cTNI) 
during embryogenesis. A few years ago Millino et al. 
published a study on transgenic mice [13] showing 
that depending on TNI promoter length lacZ reporter 
gene was either expressed only in the atria or also in 
PVs, and hypothesized that cardiomyocytes of atria 
and PVs show differences in their transcriptional 
potential. However, in light of the more recent data of 
Mommersteeg it is likely, that the observed differences 
in transcription are due to the existence of two 
different myocardial cell populations in terms of origin 
in mice. Interestingly, these two cell populations differ 
in their sensitivity to genetic disturbance, being the PV 
cardiomyocytes more susceptible to a nodal-type 
phenotype shift [14]. Based on these observations, 
Mommersteeg and collaborators suggested that in 
humans, genetic variations between individuals might 
trigger PV cardiomyocyte phenotype shift, 
automaticity, and finally atrial fibrillation. Our results 
support this hypothesis. First, we found that human 
PV cardiomyocytes possess the working myocardium 
phenotype as predicted by the embryological studies 
of Mommersteeg. Second, the strong individual 
variability in human PV cardiomyocite coverage and 
distribution fits well with a model in which genetic 
variation accounts for a variable atrial fibrillation 
susceptibility. 
Taking the results of the present study together 
with previous embryological research, and assuming 
that the physiological function of murine PV 
cardiomyocyte coverage has been lost in other 
mammals like humans, we propose that in man PV 
cardiomyocytes may represent a relict of PV 
embryogenesis, constituting a source of ectopic 
generation of independent re-entrant wavelets in a 
subset of patients with a genetic predisposition. This 
annotation might be a substantial working hypothesis 
for further experimental investigations in other 
mammals like guinea pigs in which cardiomyocytes 
only extend to the hilus [4] and spontaneous electrical 
activity has been observed. 
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